# PeptiSync vs Ascend

The clearest difference is rating: PeptiSync at 5.0 against Ascend's 4.7. PeptiSync also leads on device support (3 vs 1) and iOS requirement (13.0 vs 17.0). Ascend's advantage is ratings volume (18 vs 2). On price, update cadence, ads and in-app purchases there is nothing between them.

Both are free to download. PeptiSync sells 7 in-app purchases, starting at $4.99 per month and Ascend sells 3 in-app purchases, starting at $9.99 per month. Whichever you choose, the download price is not the number that matters.

PeptiSync holds the better App Store score, 5.0 against 4.7. That said, the two scores are not equally well evidenced: Ascend has 18 ratings behind it against 2, so its average is the more settled of the two.

PeptiSync ships an update every 3 days, Ascend weekly. The most recent releases landed on September 23, 2026 and September 24, 2026 respectively.

## The numbers

| Metric | PeptiSync | Ascend |
| --- | --- | --- |
| Price | Free | Free |
| Rating | **[5.0 (2 ratings)](https://appshunter.io/ios/app/peptisync/id6754933334/reviews)** | [4.7 (18 ratings)](https://appshunter.io/ios/app/ascend-peptide-tracker/id6755852284/reviews) |
| Number of ratings | 2 | **18** |
| Positive reviews | — | 80.0% of reviews |
| In-app purchases | Yes | Yes |
| Ads | No | No |
| Update frequency | **Every 3 days** | Weekly |
| Monetization | Freemium | Freemium |
| Size | 97 MB | 311 MB |
| Requires iOS | **13.0** | 17.0 |
| Devices | **iPhone, iPad, iPod** | iPhone |
| Age rating | 17+ | 12+ |
| Developer | [PeptiSync](https://appshunter.io/developer/1850982029) | [Michael Zhu](https://appshunter.io/developer/1856720667) |

## What reviewers say

### PeptiSync

[App page](https://appshunter.io/ios/app/peptisync/id6754933334)

This app helps users manage peptide therapy by tracking doses, inventory, progress, and symptoms. It offers a curated library of peptides and vendor price comparisons, all within a secure and private environment.

**Highlights:** Comprehensive dose tracking, Visual progress tracking, Inventory management, Analytics and insights, Symptom and side effect logging, Peptide library, Vendor price comparison

**Features:** macOS Compatibility

**In-app purchases (7)**

| Purchase | Price | Billing |
| --- | --- | --- |
| Basic Monthly | $4.99 | per month |
| Pro Monthly | $9.99 | per month |
| Pro Plus Monthly | $19.99 | per month |
| Basic Yearly | $54.99 | per year |
| Pro Yearly | $99.99 | per year |
| Elite Annual | $179.99 | per year |
| Pro Plus Yearly | $199.99 | per year |


### Ascend

[App page](https://appshunter.io/ios/app/ascend-peptide-tracker/id6755852284)

This app helps users track their peptide usage, including specific compounds like Retatrutide and Ozempic. It offers features for logging doses, managing side effects, and monitoring nutrition, providing a centralized platform for peptide journey management.

**Highlights:** All-in-one peptide journey tracking, Smart AI-powered food logging, Dose reconstitution calculator, Peptide library with detailed info, Side effect management, Dose reminders

**In-app purchases (3)**

| Purchase | Price | Billing |
| --- | --- | --- |
| Ascend | $9.99 | per month |
| Ascend | $29.99 | per year |
| Unlimited | $39.99 | per year |


## Frequently asked questions

### Is PeptiSync free?

PeptiSync is free to download, with in-app purchases available.

### Is Ascend free?

Ascend is free to download, with in-app purchases available.

### Which has better reviews, PeptiSync or Ascend?

PeptiSync is rated higher. PeptiSync averages 5.0 out of 5 from 2 ratings, while Ascend averages 4.7 from 18 ratings.

### Do PeptiSync or Ascend have ads?

Neither PeptiSync nor Ascend shows ads.

### Which is updated more often, PeptiSync or Ascend?

PeptiSync ships an update every 3 days, and Ascend weekly. Most recently, PeptiSync was updated on September 23, 2026 and Ascend on September 24, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*